STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

HIMS insider filings show 900-share Rule 144 sale; $52,425 value

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Hims & Hers Health, Inc. notice reports a proposed sale of 900 Class A shares through Fidelity Brokerage Services LLC on 10/10/2025 with an aggregate market value of $52,425. The filer indicates the shares derive from an option granted on 08/10/2022 and show cash payment on the stated sale date. The filing lists recent insider sales by Michael Y. Chi totaling $4,240,268.50 across eight transactions between 07/23/2025 and 10/01/2025.

The notice includes the required representation that the seller does not possess undisclosed material adverse information and identifies this as a Rule 144 notice of proposed sale. No earnings, guidance, or other operational metrics are disclosed in this form.

Positive

  • Transparency of planned sale via Form 144 with broker and sale date disclosed
  • Shares originate from documented option grant (granted 08/10/2022) showing standard vesting/exercise mechanics

Negative

  • Multiple recent insider sales totaling $4,240,268.50 may signal ongoing insider liquidity needs
  • Filing lacks contextual disclosure about purpose of sales or holdings post-transaction

Insights

TL;DR: A small scheduled Rule 144 sale (900 shares) follows multiple recent insider dispositions totaling over $4.24M.

The filing documents a planned disposal of 900 Class A shares on 10/10/2025 via Fidelity Brokerage Services LLC. The shares stem from an option granted on 08/10/2022 and are slated to be paid in cash, consistent with routine option exercise-and-sale activity.

Recent recorded sales by Michael Y. Chi span eight transactions from 07/23/2025 to 10/01/2025, with aggregate gross proceeds of $4,240,268.50, which is relevant for monitoring ongoing insider liquidity but is not a regulatory finding. Monitor near-term insider selling volumes and any public disclosures that provide context within 30 days.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the HIMS Form 144 disclose about the proposed sale?

It reports a proposed sale of 900 Class A shares through Fidelity Brokerage Services on 10/10/2025 with an aggregate market value of $52,425.

Who is recorded as selling shares in recent transactions for HIMS?

The filing lists insider sales by Michael Y. Chi between 07/23/2025 and 10/01/2025, totaling $4,240,268.50 in gross proceeds.

What is the origin of the 900 shares being sold?

The 900 shares derive from an option granted on 08/10/2022 and the filing indicates payment will be made in cash on the sale date.

Does the Form 144 state the seller has undisclosed material information?

By signature, the seller represents they do not know any undisclosed material adverse information about the issuer at the time of the notice.

Which exchange will the proposed sale occur on?

The proposed sale is listed for the NYSE using Fidelity Brokerage Services LLC as the broker.
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data

9.11B
204.92M
10.63%
88.99%
33.02%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
Link
United States
SAN FRANCISCO